U.S. market Closed. Opens in 5 hours 50 minutes

LOGC | LogicBio Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue287.00M571.00M2.08B2.54BN/AN/AN/AN/A
Cost of Revenue228.00M405.00M977.00M947.00MN/AN/AN/AN/A
Gross Profit59.00M166.00M1.11B1.59BN/AN/AN/AN/A
Operating Expenses387.00M564.00M1.48B2.23B41.04M17.94M5.85MN/A
Selling, General & Admin235.00M370.00M1.27B2.00B10.38M6.86M2.30M1.37M
Research & Development152.00M194.00M208.00M222.00M30.66M11.08M3.56M2.03M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-328.00M-398.00M-367.00M-631.00M-41.04M-17.94M-5.85M-3.40M
Other Expenses / Income16.00M15.00M-1.07M-110.00M935.00K408.00K121.00K-7.00K
Before Tax Income-312.00M-383.00M-351.00M-743.00M-40.11M-17.54M-5.73M-3.41M
Income Tax Expenses5.00M1.00M10.00M2.00M22.00K86.00K62.00K18.00K
Net Income-317.00M-384.00M-361.00M-745.00M-40.13M-17.62M-5.79M-3.43M
Interest ExpensesN/AN/A1.07M1.10M546.00K567.00KN/A1.00K
Basic Shares Outstanding23.73M22.41M20.97M4.23M22.60M5.80M8.42M13.67M
Diluted Shares Outstanding23.73M22.41M20.97M4.23M22.60M5.80M8.42M13.67M
EBITDA-324.00M-392.00M-358.00M-509.00M-39.27M-17.45M-5.69M-3.39M
EBITDA Margin-112.89%-68.65%-17.17%-20.03%0.00%0.00%0.00%0.00%
EBIT-312.00M-383.00M-349.93M-741.90M-39.56M-16.97M-5.73M-3.41M
EBIT Margin-108.71%-67.08%-16.78%-29.20%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙